¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"maximum expiratory flow"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximum compliance
    ÃÖ´ë¼øÀÀµµ
  • maximum dose
    1. ÃÖ´ë¿ë·® 2. ÃÖ´ë¼±·®
  • maximum gradient strength
    ÃÖ´ë±â¿ï±â¼¼±â, ÃÖ´ë°æ»ç°­µµ
  • maximum heart rate
    ÃÖ´ë½ÉÀå¹Úµ¿¼ö, ÃÖ´ë½É¹Ú¼ö
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
  • maximum power output
    ÃÖ´ëÃâ·Â
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
  • maximum security unit
    ÃÖ´ë¾ÈÀüº´µ¿
  • maximum tolerance dose
    1. ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·® 2. ÃÖ´ë°ßµõ¼±·®
  • maximum urea clearance
    ÃÖ°í¿ä¼Òû¼Ò, ÃÖ°í¿ä¼Òû¼ÒÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximum acceptable daily intake
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®
  • maximum allowable limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
  • maximum
    ÃÖ´ë
  • maximum transport
    ÃÖ´ë¿î¹ÝÄ¡, ÃÖ´ëÀ̵¿Ä¡
  • maximum allowable value
    ÃÖ´ëÇã¿ëÄ¡
  • maximum articulation score
    ÃÖ°í¸í·áµµ
  • maximum cardiac output
    ÃÖ´ë½ÉÀå¹ÚÃâ·®
  • maximum discrimination score
    ÃÖ´ë¸í·áµµ
  • maximum gradient strength
    ÃÖ´ë°æ»ç¼¼±â, ÃÖ´ë±â¿ï±â¼¼±â
  • maximum heart rate
    ÃÖ´ë½ÉÀå¹Úµ¿¼ö
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gas flow meter
    ±âüÀ¯¼Ó°è(¡­êüáÜͪ).
  • hepatic blood flow
    °£Ç÷·ù(·®)(ÊÜúì×µ).
  • hepatic blood flow
    °£Ç÷·ù(·®).
  • high flow method
    °íÀ¯·®¹ý(ÍÔêüåÖÛö).
  • in-flow effect
    À¯ÀÔ È¿°ú
  • in-plane flow misregistration
    Æò¸é³» À¯µ¿ ¿Àµî·Ï
  • inspiratory triggering flow
    Èí±âÀ¯¹ß±â·ù.
  • pressure flow study
    ¾Ð·ù·® Á¶»ç
  • pulmonary blood flow
    ÆóÇ÷·ù·®(øËúìêüåÖ).
  • pulmonary flow resistance
    Æó±â·ùÀúÇ×(øËѨêüî½ù÷).
  • pyelointerstitial back flow
    ½Å¿ì°£Áú¼º¿ª·ù
  • pyelotubular back flow
    ½Å¿ì¼¼¿ä°ü¼º¿ª·ù
  • quantitative flow measurement
    Á¤·®Àû À¯·® ÃøÁ¤
  • rate of flow
    ¹æ¼ö·ù·®, ¹æ¼ö»ý»ê·®
  • renal blood flow
    ½ÅÇ÷·ù·®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • forced expiratory volume =FEV
    °­Á¦È£±â(ÆóȰ)·®, ³ë·ÂÈ£±âÆóȰ·®
  • inspiratory expiratory ratio
    ÈíÈ£±â´ëºñ.
  • inspiratory expiratory valve
    ÈíÈ£±â¹ëºê.
  • maximal expiratory level
    ÃÖ´ëÈ£±âÀ§(¡­û¼Ñ¨êÈ).
  • positive and expiratory pressure
  • positive end expiratory pressure =PEE
    È£±â¸»¾ç¾Ð.
  • positive end expiratory pressure =PEEP
    È£±â¸»¾ç¾Ð.
  • resting expiratory level
    ¾ÈÁ¤È£±â(äÌð¡û¼Ñ¨)·¹º§.
  • zero end expiratory pressure =ZEEP
    È£±â¸»¹«(¿µ)¾Ð.
  • apex beat =point of maximum impulse
    ½É÷¹Úµ¿(ãýôÓÚÑÔÑ)
  • articulation score, maximum
    ÃÖ°í¸í·áµµ
  • discrimination score, maximum
    ÃÖ´ë¸í·áÄ¡
  • maximum absorption
    ÃÖ´ëÈí¼ö.
  • maximum acceptable daily intake =MADI
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®(ìéìíàîö¢õÌÓÞúÉé»åÖ).
  • maximum acceptable daily intake =MADI
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®(ËöËöËÛ̧̬ËÀÌ´ËíËâ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • windowless gas flow counter
    ¹«Ã¢(Ùíóë) °¡½º È帧 °èÃø±â(ͪö´Ðï)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • high intensity proton flow
    °í°­µµ¾çÀÚÀ¯µ¿
  • in-flow effect
    À¯ÀÔ È¿°ú
  • in-plane flow misregistration
    Æò¸é³»À¯µ¿¿Àµî·Ï
  • laminar flow
    Ãþ·ù
  • liver blood flow
    °£ÀåÇ÷¾×À¯Åë, °£Ç÷·ù
  • low intensity void in proton flow
    ¾ç¼ºÀÚÈ帧ÀÇ Àú°­µµ¼Ò½Ç
  • parabolic flow
    Æ÷¹°¼±ÇüÀ¯Ã¼È帧
  • plug flow
    Àü·ù
  • proton flow
    ¾çÀÚÀ¯µ¿
  • proton flow abnormality
    ¾çÀÚÀ¯µ¿ÀÌ»ó
  • proton flow deficit
    ¾çÀÚÀ¯µ¿°áÇÌ
  • pseudodiastole in high intensity proton flow
    °í°­µµ¾çÀÚÀ¯µ¿¿¡¼­ À§À̿ϱâ
  • quantitative flow measurement
    Á¤·®ÀûÀ¯·®ÃøÁ¤
  • turbulent flow
    ¿Í·ù, ³­·ù
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MEP maximum expiratory pressure; mean effective pressure; mepiridine; mitochondrial encephalopathy; moto...
PEmax maximum expiratory pressure
Dmax maximum denaturation; maximum diameter
MAC MacConkey [broth]; major ambulatory category; malignancy-associated changes; maximum allowable conce...
MCP maximum closure pressure; maximum contraction pattern; malanocortin receptor; melphalan, cyclophosph...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FEF(25-75) forced expiratory flow
FEF25-75 forced expiratory flow between 25 and 75% of vital capacity
MMFR maximal mid expiratory flow rate
MFR Maximum flow rate
auto-PEEP Auto-positive end expiratory pressure
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maximum surgical blood order schedule
    ÃÖ´ë ¼ö¼ú Ç÷¾× ¿äû ¿¹Á¤Ç¥
  • maximum tolerance dose
    ÃÖ´ë ³»¿ë·®, ÃÖ´ë °ßµõ ¼±·®
  • maximum urethral closure pressure
    ÃÖ°í ¿äµµ Æó¼â¾Ð
  • maximum vapor tension
    ÃÖ´ë Áõ±â Àå·Â
  • air flow
    ±â·ù
  • aqueous flow
    ¹æ¼ö È帧, ¹æ¼ö·ù
  • blood flow pattern
    Ç÷·ù ¾ç»ó
  • blood flow velocity
    Ç÷·ù ¼Óµµ
  • bulk flow
    µ¢¾î¸® È帧
  • color Doppler flow mapping
    »ö µµÇ÷¯ Ç÷·ù ÁöµµÈ­
  • color flow imaging
    »öÇ÷·ù ¿µ»ó
  • continuous flow blood analysis
    Áö¼Ó¼º À¯µ¿ Ç÷¾× ºÐ¼®
  • coronary blood flow
    °üÇ÷·ù, °ü»ó Ç÷·ù
  • counter current flow
    ¿ªÈ帧, °Å²Ù·Î È帧, ¿ª·ù
  • counter flow
    ´ëÇâ·ù, ¿ª·ù, ¹Ý·ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
gene flow The movement of genes from one population to another viainterbreeding.
(09 Oct 1997)
maximal midexpiratory flow rate Measurement of rate of airflow over the middle half of a forced vital capacity determination (from the 25 percent level to the 75 percent level). Common abbreviations are mmfr and fef 25%-75%.
(12 Dec 1998)
renal blood flow, effective The amount of blood flowing to the parts of the kidney that are involved with the production of constituents of urine. It is that portion of the total renal blood flow that perfuses functional renal tissue (e.g., the glomeruli). It should be differentiated from renal plasma flow, effective which is based on the amount of plasma rather than on total renal blood.
(12 Dec 1998)
renal plasma flow <physiology> The amount of plasma that perfuses the kidneys per unit time, approximately 10% greater than effective renal plasma flow.
It should be differentiated from the renal blood flow which refers to the total volume of blood flowing through the renal vasculature, while the renal plasma flow refers to the rate of plasma flow.
(12 Dec 1998)
peak flow <chest medicine, physiology> The maximum flow rate of air breathed out during forced expiration.
(15 Nov 1997)
peak flow rate Maximum urinary flow rate during voiding as measured by a uroflowmeter.
(05 Mar 2000)
voiding flow rate Urinary flow as a function of time during micturition, as graphically recorded by a flow meter.
(05 Mar 2000)
cytometry, flow Analysis of biological material by detection of the light-absorbing or fluorescing properties of cells or subcellular fractions such as chromosomes passing in a narrow stream through a laser beam. Flow cytometry is used with automated sorting devices to sort successive droplets of the stream into different fractions depending on the fluorescence emitted by each droplet.
(12 Dec 1998)
pulsatile flow Rhythmic, intermittent propagation of a fluid through a vessel or piping system, in contrast to constant, smooth propagation, which produces laminar flow. The quality of blood flow, whether smooth (laminar) or pulsatile, is important to the integrity of the tissues being artificially perfused by various heart assist devices or in regional perfusion.
(12 Dec 1998)
sheared flow <radiobiology> Fluid flow where the magnitude of the fluid velocity changes along a direction perpedicular to the direction of the fluid flow. (Freeway traffic often exhibits sheared flow in that traffic in the fast lane moves more rapidly than traffic in the slow lane with the exits.) Sheared flow typically correlates with reduced transport and enhanced confinement. (This definition is rather informal and may not be fully technically correct - R.F. Heeter)
(09 Oct 1997)
shear flow A flow of a material in which parallel planes in the material are displaced in a direction parallel to each other.
(05 Mar 2000)
shuttle flow <cell biology> Bulk flow of the cytoplasm of cells. most conspicuous in large cells such as amoebae and the internodal cells of Chara where the rate of movement may be as high as 100 m/sec.
See: cyclosis.
(18 Nov 1997)
newtonian flow The type of flow characteristic of a newtonian fluid.
(05 Mar 2000)
Doppler colour flow A computer-generated colour image produced by Doppler ultrasonography in which different directions of flow are represented by different hues.
This technique is typically used to examine blood flow when evaluating heart disease. Where obstructions (for instance, arterial plaques) exist, blood flow will alter according to the principles of fluid mechanics. Eddies and reversals are readily apparent on the colour image.
See: Doppler ultrasonography.
(05 Mar 2000)
instream flow incremental methodology Technique to predict the biomass of a fish species or life stage that a stream reach can support at a given flow, given knowledge of the fishes' physical habitat preferences.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á